In a patient with salmonella infection, which of the following comorbidities—myasthenia gravis, chronic kidney disease, cirrhosis, or penicillin allergy—is an absolute contraindication to antibiotic therapy?

Myasthenia Gravis is the Contraindication

In a patient with salmonella infection, myasthenia gravis represents the most critical contraindication when selecting antibiotic therapy, specifically for fluoroquinolones (ciprofloxacin, levofloxacin), which are the first-line agents for salmonella treatment.

Why Myasthenia Gravis is the Answer

Fluoroquinolones are the drugs of choice for salmonella infections requiring treatment 1, 2, 3. However, these antibiotics carry a well-documented risk of exacerbating myasthenia gravis, potentially triggering myasthenic crisis requiring mechanical ventilation 4, 5. The FDA has issued strengthened warnings about fluoroquinolone use in MG patients 6.

The clinical significance is substantial: While MG exacerbation occurs in approximately 2.4% of ciprofloxacin exposures and 1.6% of levofloxacin exposures, when it does occur, it can be severe—with impending crisis or frank myasthenic crisis requiring rescue therapy 4. This represents a direct threat to mortality through respiratory failure 5.

Why the Other Options Are Not Contraindications

Chronic Kidney Disease

• Not a contraindication, just requires dose adjustment
• Fluoroquinolones can be used with appropriate renal dosing modifications
• While salmonella can cause acute renal dysfunction 7, this doesn't contraindicate treatment—it necessitates monitoring

Cirrhosis

• Not a contraindication
• Immunocompromised patients with cirrhosis actually have increased indication for treating salmonella due to risk of invasive disease 8, 9
• Fluoroquinolones are hepatically metabolized but not absolutely contraindicated in liver disease

Penicillin Allergy

• Irrelevant for salmonella treatment
• First-line salmonella therapy uses fluoroquinolones, not penicillins 2
• Even if penicillins were considered (ampicillin is an alternative for susceptible organisms 2), 90% of reported penicillin allergies are false labels 10
• Penicillins may actually exacerbate MG themselves 11, but are not first-line for salmonella

Treatment Algorithm for Salmonella with MG

If the patient has myasthenia gravis:

1. Avoid fluoroquinolones (ciprofloxacin, levofloxacin) as first-line

2. Use alternative agents based on susceptibility:

   • TMP-SMX (if susceptible) 2
   • Ceftriaxone 2
   • Azithromycin 2
   • Ampicillin (if susceptible, though may also exacerbate MG 11)

3. Consider treatment necessity: For uncomplicated nontyphoidal salmonella gastroenteritis, antibiotics are often not indicated unless the patient has high-risk features (immunosuppression, age >50 with atherosclerosis, valvular disease) 2

4. Monitor closely: If fluoroquinolones must be used due to resistance patterns, hospitalize the patient with respiratory monitoring capability 5

Critical Pitfall

The most dangerous error would be prescribing ciprofloxacin—the standard first-line agent for salmonella 1, 3—to a patient with myasthenia gravis without considering the risk of precipitating respiratory failure. This represents a direct mortality risk that supersedes the other comorbidities listed.